Trials / Completed
CompletedNCT00108979
Study of Escitalopram in Adult Patients With Major Depressive Disorder
Double-Blind Study of Escitalopram in Adult Patients With Major Depressive Disorder
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 240 (planned)
- Sponsor
- Forest Laboratories · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Escitalopram is the S-enantiomer of citalopram. Both escitalopram and citalopram are selective serotonin reuptake inhibitors (SSRIs) and are used to treat depression in adults. This study is designed to evaluate the efficacy, safety, and pharmacoeconomics of escitalopram and an active comparator in patients with major depressive disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Escitalopram |
Timeline
- Start date
- 2005-03-01
- Primary completion
- 2006-07-01
- Completion
- 2006-07-01
- First posted
- 2005-04-22
- Last updated
- 2012-03-05
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00108979. Inclusion in this directory is not an endorsement.